Status | Study |
Recruiting |
Study Name: Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa Condition: Retinitis Pigmentosa Date: 2013-07-31 Interventions: Biological: BMMNCs Intervention therapy , Total 3 doses ,in 30 days ,in 7days interval ,transfer of Auto |
Completed |
Study Name: Acupuncture for the Treatment of Vision Loss Due to Retinitis Pigmentosa Condition: Retinitis Pigmentosa Date: 2012-05-21 Interventions: Procedure: Electro-acupuncture Ten treatment sessions at our center during a two week period (5 sessions |
Not yet recruiting |
Study Name: Feasibility and Safety of Adult Human Bone Marrow-derived Mesenchymal Stem Cells by Intravitreal Injection in Patients With Retinitis Pigmentosa Condition: Retinitis Pigmentosa Date: 2012-02-06 Interventions: Other: Intravitreal injection of bone marrow-derived mesenchymal stem cells Bone marrow-derived mesenchy |
Completed |
Study Name: Trial of Oral Valproic Acid for Retinitis Pigmentosa Condition: Retinitis Pigmentosa Date: 2010-11-01 Interventions: Drug: Valproic Acid One to fou |
Completed |
Study Name: Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa Condition: Retinitis Pigmentosa Date: 2010-02-10 Interventions: Biological: intravitreal injection of autologous bone marrow stem cells One intravitreal injection of a |
Completed |
Study Name: Stress and Vision Fluctuations in Retinitis Pigmentosa Condition: Retinitis Pigmentosa Date: 2007-05-16 |
Terminated |
Study Name: A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosa Condition: Retinitis Pigmentosa Date: 2007-04-10 Interventions: Drug: CNTO 2476 Participant 1 will receive 5.6x100000; Participants 2, 3, 5, 6, and 7 will receive 6.0x1 |
Completed |
Study Name: A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa Condition: Retinitis Pigmentosa Date: 2007-03-09 Interventions: Drug: NT-501 High Dose |
Completed |
Study Name: A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa Condition: Retinitis Pigmentosa Date: 2007-03-09 Interventions: Drug: NT-501 High Dose |
Completed |
Study Name: Safety Study in Retinal Transplantation for Retinitis Pigmentosa. Condition: Retinitis Pigmentosa. Date: 2006-06-28 Interventions: Device: Retinal transplantation instrument |